Centre De Recherche Du Centre Hospitalier Universitaire De Sherbrooke

This study tests a special PET scan that uses a radioactive tracer to find low levels of HER2 protein in metastatic breast cancer. About 40 adults with HER2-low breast cancer will receive an injection of the tracer and be scanned 3-6 days later. The goal is to see if this scan ca…